JAK2 and myeloproliferative neoplasm: Further on, MPN patients were divided into thrombotic and non‐thrombotic groups, and their clinical characteristics, CBC results, driver mutation status and JAK2 V617F mutational load are displayed in Table 2, without significant differences between the two MPN groups.